scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1365-2826.2002.00836.X |
P698 | PubMed publication ID | 12213137 |
P2093 | author name string | Holsboer F | |
Uhr M | |||
Müller MB | |||
P2860 | cites work | Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure | Q28346146 |
Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption | Q28372143 | ||
Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities | Q33495468 | ||
The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety | Q33658043 | ||
Multiple physiological functions for multidrug transporter P-glycoprotein? | Q33818793 | ||
Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites | Q33832954 | ||
Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease | Q33885755 | ||
Mini-review: in vivo neurogenesis in the adult brain: regulation and functional implications | Q34007390 | ||
The corticosteroid receptor hypothesis of depression | Q34057906 | ||
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs | Q34059522 | ||
Control of neuronal excitability by corticosteroid hormones | Q35318038 | ||
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins | Q36108920 | ||
The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues | Q36768537 | ||
Profound differences in the transport of steroids by two mouse P-glycoproteins | Q40929456 | ||
The physiological function of drug-transporting P-glycoproteins | Q41688645 | ||
Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. | Q43892559 | ||
Blood-brain barrier: endogenous modulation by adrenal-cortical function | Q48506183 | ||
P433 | issue | 9 | |
P921 | main subject | cortisol | Q190875 |
P1104 | number of pages | 7 | |
P304 | page(s) | 753-759 | |
P577 | publication date | 2002-09-01 | |
P1433 | published in | Journal of Neuroendocrinology | Q3186929 |
P1476 | title | Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins | |
P478 | volume | 14 |
Q57189948 | A Membrane Transporter Is Required for Steroid Hormone Uptake in Drosophila |
Q48082618 | A multidrug resistance transporter in Magnaporthe is required for host penetration and for survival during oxidative stress |
Q42000125 | A rapid release of corticosteroid-binding globulin from the liver restrains the glucocorticoid hormone response to acute stress. |
Q38290046 | A revised role for P-glycoprotein in the brain distribution of dexamethasone, cortisol, and corticosterone in wild-type and ABCB1A/B-deficient mice |
Q36510891 | ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response |
Q40571639 | ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder |
Q92105413 | ABCB1 Gene Is Associated With Clinical Response to SNRIs in a Local Chinese Han Population |
Q40164197 | Adaptive response to increased bile acids: induction of MDR1 gene expression and P-glycoprotein activity in renal epithelial cells |
Q47117893 | Adrenal corticosteroid effects in the central nervous system on long-term control of blood pressure |
Q35806723 | Aging and stress: past hypotheses, present approaches and perspectives |
Q46830595 | Aldosterone acts centrally to increase brain renin-angiotensin system activity and oxidative stress in normal rats |
Q24658160 | Aldosterone in the brain |
Q57807609 | Aldosterone-sensitive HSD2 neurons in mice |
Q35173847 | Aldosterone: its receptor, target genes, and actions |
Q64967468 | Alterations in Expression and Function of ABC Family Transporters at Blood-Brain Barrier under Liver Failure and Their Clinical Significances. |
Q36440253 | Antenatal steroids and the IUGR fetus: are exposure and physiological effects on the lung and cardiovascular system the same as in normally grown fetuses? |
Q41947488 | Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters |
Q38632276 | Association Between ABCB1 Gene Polymorphism and Renal Function in Patients with Hypertension: A Case-Control Study. |
Q49990441 | Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia |
Q52950284 | Atypical depression spectrum disorder - neurobiology and treatment. |
Q48008520 | Behavioural consequences of p-glycoprotein deficiency in mice, with special focus on stress-related mechanisms |
Q44719752 | Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice |
Q37416133 | CYP3A5 and ABCB1 genes and hypertension |
Q35898051 | Candidate mechanisms for chemotherapy-induced cognitive changes |
Q37298913 | Canine ABCB1 and macrocyclic lactones: heartworm prevention and pharmacogenetics |
Q41811241 | Central nervous system (CNS) delivery of glucocorticoids is fine-tuned by saturable transporters at the blood-CNS barriers and nonbarrier regions |
Q37667680 | Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury |
Q33533964 | Cerebrospinal fluid cortisol levels are higher in patients with delirium versus controls |
Q41508060 | Changes in the brain accumulation of glucocorticoids in abcb1a-deficient CF-1 mice |
Q33770596 | Changes in the placental glucocorticoid barrier during rat pregnancy: impact on placental corticosterone levels and regulation by progesterone |
Q48407386 | Concentrations of estradiol in ewe cerebrospinal fluid are modulated by photoperiod through pineal-dependent mechanisms |
Q36392570 | Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis. |
Q38560579 | Desipramine treatment has minimal effects on the brain accumulation of glucocorticoids in P-gp-deficient and wild-type mice |
Q36418615 | Determinants and significance of corticosterone regulation in the songbird brain |
Q44612600 | Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption |
Q37369136 | Dissociation between rat hippocampal CA1 and dentate gyrus cells in their response to corticosterone: effects on calcium channel protein and current. |
Q46802337 | Distribution of androstenedione and its effects on total free fatty acids in pregnant rats |
Q42627340 | Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice |
Q37465538 | Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure? |
Q37514340 | Drug transporters: gatekeepers controlling access of xenobiotics to the cellular interior |
Q34102899 | Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II. |
Q46727021 | Effects of acute or 3-day treatments of Hypericum caprifoliatum Cham. & Schltdt. (Guttiferae) extract or of two established antidepressants on basal and stress-induced increase in serum and brain corticosterone levels |
Q48565579 | Effects of antidepressants on the brain/plasma distribution of corticosterone |
Q42705654 | Effects of the ABCB1 (1199G > A) Polymorphism on Steroid Sex Hormone-Induced P-Glycoprotein Expression, ATPase Activity, and Hormone Efflux |
Q36091591 | Endocrine disturbances in depression |
Q87052025 | Estimation of cerebrospinal fluid cortisol level in tuberculous meningitis |
Q37987922 | Evidence and consequences of the central role of the kidneys in the pathophysiology of sympathetic hyperactivity |
Q46365946 | Evolutionarily Conserved Roles for Blood-Brain Barrier Xenobiotic Transporters in Endogenous Steroid Partitioning and Behavior |
Q36439391 | Fetal glucocorticoid synthesis is required for development of fetal adrenal medulla and hypothalamus feedback suppression |
Q34186724 | Free diffusion of steroid hormones across biomembranes: a simplex search with implicit solvent model calculations |
Q46846896 | Frequency of the nt230 (del4) MDR1 mutation in Collies and related dog breeds in Germany |
Q51837355 | High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension. |
Q42468905 | Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein |
Q53799638 | Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs. |
Q48344085 | Implication of P-glycoprotein in formation of depression-prone personality: association study between the C3435T MDR1 gene polymorphism and interpersonal sensitivity |
Q35708089 | Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings |
Q52670324 | Measurement of Rhodamine 123 in Three-Dimensional Organoids: A Novel Model for P-Glycoprotein Inhibitor Screening. |
Q37334088 | Mechanisms of antidepressant resistance |
Q42949286 | Mineralocorticoid and glucocorticoid receptors in sciatic nerve function and regeneration |
Q46496811 | Modulation of intestinal transport of 2,4-dinitrophenyl-S-glutathione, a multidrug resistance-associated protein 2 substrate, by bilirubin treatment in rats |
Q35209207 | Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress |
Q44710801 | Olanzapine penetration into brain is greater in transgenic Abcb1a P-glycoprotein-deficient mice than FVB1 (wild-type) animals |
Q40529116 | P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro |
Q44485055 | P-glycoprotein attenuating effect of human intestinal fluid. |
Q44858867 | P-glycoprotein reduces the ability of amitriptyline metabolites to cross the blood brain barrier in mice after a 10-day administration of amitriptyline |
Q44553328 | Passage of progesterone into the brain changes with photoperiod in the ewe. |
Q35827367 | Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction |
Q58746190 | Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta |
Q36544614 | Preface: the concept and consequences of multidrug resistance |
Q34068347 | Region-specific neural corticosterone patterns differ from plasma in a male songbird |
Q35740275 | Regulation of corticoid and serotonin receptor brain system following early life exposure of glucocorticoids: long term implications for the neurobiology of mood |
Q34630688 | Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism |
Q37366788 | Self-administered and passive cocaine infusions produce different effects on corticosterone concentrations in the medial prefrontal cortex (MPC) of rats. |
Q37678091 | The Arcuate Nucleus: A Site of Fast Negative Feedback for Corticosterone Secretion in Male Rats. |
Q24796928 | The Renin-Angiotensin-Aldosterone system in patients with depression compared to controls – a sleep endocrine study |
Q36439650 | The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells |
Q44464123 | The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones |
Q42171425 | The antidepressant desipramine requires the ABCB1 (Mdr1)-type p-glycoprotein to upregulate the glucocorticoid receptor in mice |
Q28395237 | The blood-testis barrier and its implications for male contraception |
Q37024001 | The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient. |
Q37569418 | The mammalian mineralocorticoid receptor: tying down a promiscuous receptor |
Q44530572 | The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone |
Q36510902 | The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases |
Q35925779 | Therapeutic implications of the MDR-1 gene |
Q37196030 | Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice |
Q36285918 | Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine |
Q37951034 | Treatment of MDR1 mutant dogs with macrocyclic lactones |
Q41133269 | Utility of cerebrospinal fluid cortisol level in acute bacterial meningitis |
Q33714593 | Xenobiotic, bile acid, and cholesterol transporters: function and regulation. |
Q44371297 | abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice |
Search more.